TY - JOUR
T1 - Cost-Effectiveness of Peer- Versus Venue-Based Approaches for Detecting Undiagnosed HIV Among Heterosexuals in High-Risk New York City Neighborhoods
AU - Stevens, Elizabeth R.
AU - Nucifora, Kimberly A.
AU - Zhou, Qinlian
AU - Braithwaite, Ronald Scott
AU - Cleland, Charles M.
AU - Ritchie, Amanda S.
AU - Kutnick, Alexandra H.
AU - Gwadz, Marya V.
N1 - Publisher Copyright:
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2018/2/1
Y1 - 2018/2/1
N2 - Introduction: We used a computer simulation of HIV progression and transmission to evaluate the cost-effectiveness of a scale-up of 3 strategies to seek out and test individuals with undiagnosed HIV in New York City (NYC). Setting: Hypothetical NYC population. Methods: We incorporated the observed effects and costs of the 3 “seek and test” strategies in a computer simulation of HIV in NYC, comparing a scenario in which the strategies were scaled up with a 1-year implementation or a long-term implementation with a counter-factual scenario with no scale-up. The simulation combined a deterministic compartmental model of HIV transmission with a stochastic microsimulation of HIV progression, calibrated to NYC epidemiological data from 2003 to 2015. The 3 approaches were respondent-driven sampling (RDS) with anonymous HIV testing (“RDS-A”), RDS with a 2-session confidential HIV testing approach (“RDS-C”), and venue-based sampling (“VBS”). Results: RDS-A was the most cost-effective strategy tested. When implemented for only 1 year and then stopped thereafter, using a societal perspective, the cost per quality-adjusted life-year (QALY) gained versus no intervention was $812/QALY, $18,110/QALY, and $20,362/QALY for RDS-A, RDS-C, and VBS, respectively. When interventions were implemented long term, the cost per QALY gained versus no intervention was cost-saving, $31,773/ QALY, and $35,148/QALY for RDS-A, RDS-C, and VBS, respectively. When compared with RDS-A, the incremental cost-effectiveness ratios for both VBS and RDS-C were dominated. Conclusions: The expansion of the RDS-A strategy would substantially reduce HIV-related deaths and new HIV infections in NYC, and would be either cost-saving or have favorable cost-effectiveness.
AB - Introduction: We used a computer simulation of HIV progression and transmission to evaluate the cost-effectiveness of a scale-up of 3 strategies to seek out and test individuals with undiagnosed HIV in New York City (NYC). Setting: Hypothetical NYC population. Methods: We incorporated the observed effects and costs of the 3 “seek and test” strategies in a computer simulation of HIV in NYC, comparing a scenario in which the strategies were scaled up with a 1-year implementation or a long-term implementation with a counter-factual scenario with no scale-up. The simulation combined a deterministic compartmental model of HIV transmission with a stochastic microsimulation of HIV progression, calibrated to NYC epidemiological data from 2003 to 2015. The 3 approaches were respondent-driven sampling (RDS) with anonymous HIV testing (“RDS-A”), RDS with a 2-session confidential HIV testing approach (“RDS-C”), and venue-based sampling (“VBS”). Results: RDS-A was the most cost-effective strategy tested. When implemented for only 1 year and then stopped thereafter, using a societal perspective, the cost per quality-adjusted life-year (QALY) gained versus no intervention was $812/QALY, $18,110/QALY, and $20,362/QALY for RDS-A, RDS-C, and VBS, respectively. When interventions were implemented long term, the cost per QALY gained versus no intervention was cost-saving, $31,773/ QALY, and $35,148/QALY for RDS-A, RDS-C, and VBS, respectively. When compared with RDS-A, the incremental cost-effectiveness ratios for both VBS and RDS-C were dominated. Conclusions: The expansion of the RDS-A strategy would substantially reduce HIV-related deaths and new HIV infections in NYC, and would be either cost-saving or have favorable cost-effectiveness.
KW - Cost-effectiveness
KW - Health disparities
KW - Heterosexuals
KW - HIV testing
KW - Respondent-driven sampling
KW - Undiagnosed HIV
KW - Venue-based sampling
UR - http://www.scopus.com/inward/record.url?scp=85045856669&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045856669&partnerID=8YFLogxK
U2 - 10.1097/QAI.0000000000001578
DO - 10.1097/QAI.0000000000001578
M3 - Article
C2 - 29135654
AN - SCOPUS:85045856669
SN - 1525-4135
VL - 77
SP - 183
EP - 192
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
IS - 2
ER -